I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Real-world outcomes of nivolumab plus ipilimumab and pembro..:
Matsumoto, Kinnosuke
;
Shiroyama, Takayuki
;
Tamiya, Motohiro
...
Cancer Immunology, Immunotherapy. 2024, 73(4). ,
Link:
https://ir.library.osaka-u.ac.jp/repo/ouka/all/93547/C..
RT Journal T1
Real-world outcomes of nivolumab plus ipilimumab and pembrolizumab with platinum-based chemotherapy in advanced non-small cell lung cancer: a multicenter retrospective comparative study
UL https://suche.suub.uni-bremen.de/peid=base-ftosakauniv:oai:ir.library.osaka-u.ac.jp:11094_93547&Exemplar=1&LAN=DE A1 Matsumoto, Kinnosuke A1 Shiroyama, Takayuki A1 Tamiya, Motohiro A1 Minami, Toshiyuki A1 Kinehara, Yuhei A1 Tamiya, Akihiro A1 Suga, Yasuhiko A1 Kuge, Tomoki A1 Mori, Masahide A1 Suzuki, Hidekazu A1 Tobita, Satoshi A1 Ueno, Kiyonobu A1 Namba, Yoshinobu A1 Tetsumoto, Satoshi A1 Niki, Toshie A1 Morimura, Osamu A1 Osa, Akio A1 Nishino, Kazumi A1 Nagatomo, Izumi A1 Takeda, Yoshito A1 Kijima, Takashi A1 Kumanogoh, Atsushi PB Springer Science and Business Media Deutschland GmbH K1 Ipilimumab K1 Nivolumab K1 Non-small-cell Lung cancer K1 Pembrolizumab K1 Propensity score K1 Real-world JF Cancer Immunology, Immunotherapy. 2024, 73(4) LK http://dx.doi.org/https://ir.library.osaka-u.ac.jp/repo/ouka/all/93547/CancerImmunolImmunother_73_4.pdf DO https://ir.library.osaka-u.ac.jp/repo/ouka/all/93547/CancerImmunolImmunother_73_4.pdf SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)